Trailing-twelve-month (TTM) revenue is $7.86 Billion with a year-over-year growth of +12.66%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $1,892,641,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-30 |
| Q4 FY2025Period ended 2025-12-31 | $1,998,448,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-17 |
| Q1 FY2026Period ended 2026-03-31 | $1,928,437,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-30 |
| Q2 FY2026Period ended 2026-06-30 | $2,044,397,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-04 |
| TTM revenue | $7,863,923,000 |
Current P/S: $54,153,792,810 market capitalization ÷ $7,863,923,000 TTM revenue = 6.89x.
Market capitalization source: FMP quote. Quote observed 2026-09-09T20:00:03.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $2.04B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-09T20:00:03.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Electromechanical Group | $1.6B | $1.8B | $1.9B | $2.0B | $2.3B | $2.5B |
| Electronic Instruments Group | $3.0B | $3.8B | $4.2B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Asia | $960M | $1.2B | $1.3B | $1.4B | $1.4B | $1.5B |
| European Union | $696M | N/A | N/A |
$7.86B
$7.86 Billion
+12.66%
vs. $6.98B a year ago (TTM)
+9.80%
5 Year compound annual growth rate
1 Year
+12.66%
3 Year
+6.99%
5 Year
+9.80%
10 Year
+7.24%
15 Year
+7.13%
20 Year
+8.21%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $7.40B | +$459.94M | +6.63% |
| 2024 | $6.94B | +$344.23M | +5.22% |
| 2023 | $6.60B | +$446.42M | +7.26% |
| 2022 | $6.15B | +$604.02M | +10.89% |
| 2021 | $5.55B | +$1.01B | +22.17% |
| 2020 |
TTM Growth
+12.66%
3-Year CAGR
+6.99%
5-Year CAGR
+9.80%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-09T20:00:03.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $4.7B |
| $4.9B |
| N/A |
| $1.1B |
| European Union countries | N/A | $886M | $931M | $945M | $977M | N/A |
|---|
| Non-US | $1.2B | N/A | N/A | N/A | N/A | $2.0B |
|---|
| Other foreign countries | N/A | $460M | $538M | $591M | $649M | N/A |
|---|
| Other Foreign Countries | $383M | N/A | N/A | N/A | N/A | $730M |
|---|
| United Kingdom | N/A | $217M | $210M | $214M | $234M | N/A |
|---|
| United States | N/A | $2.8B | $3.2B | $3.5B | $3.6B | N/A |
|---|
| $4.54B |
| ($618.53M) |
| (11.99%) |
| 2019 | $5.16B | +$312.69M | +6.45% |
| 2018 | $4.85B | +$545.70M | +12.69% |
| 2017 | $4.30B | +$460.08M | +11.98% |
| 2016 | $3.84B | ($134.21M) | (3.38%) |
